Esperion Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ESPR and other ETFs, options, and stocks.About ESPR
Esperion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets.
ESPR Key Statistics
Stock Snapshot
The current Esperion Therapeutics(ESPR) stock price is $3.12, with a market capitalization of 804.48M. The stock trades at a price-to-earnings (P/E) ratio of -30.14.
On 2026-05-26, Esperion Therapeutics(ESPR) stock moved within a range of $3.12 to $3.13. With shares now at $3.12, the stock is trading +0.0% above its intraday low and -0.4% below the session's peak.
Trading activity shows a volume of 6.81M, compared to an average daily volume of 9.4M.
The stock's 52-week range extends from a low of $0.76 to a high of $4.18.
The stock's 52-week range extends from a low of $0.76 to a high of $4.18.
ESPR News
Esperion (ESPR) announced the presentation of results from a Phase 2 study of bempedoic acid in children, along with an additional post hoc analysis from CLEAR...
Analyst ratings
86%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.